Cargando…
Intestinal and hepatic effects of iron oxide nanoparticles
Iron oxide nanoparticles gain increasing attention due to their broad industrial use. However, safety concerns exist since their effects on human cells are still under investigation. The presence of iron oxide nanoparticles in the food pigment E172 has been shown recently. Here, we studied four iron...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904561/ https://www.ncbi.nlm.nih.gov/pubmed/33554279 http://dx.doi.org/10.1007/s00204-020-02960-7 |
_version_ | 1783654957819363328 |
---|---|
author | Voss, Linn Hoché, Elisa Stock, Valerie Böhmert, Linda Braeuning, Albert Thünemann, Andreas F. Sieg, Holger |
author_facet | Voss, Linn Hoché, Elisa Stock, Valerie Böhmert, Linda Braeuning, Albert Thünemann, Andreas F. Sieg, Holger |
author_sort | Voss, Linn |
collection | PubMed |
description | Iron oxide nanoparticles gain increasing attention due to their broad industrial use. However, safety concerns exist since their effects on human cells are still under investigation. The presence of iron oxide nanoparticles in the food pigment E172 has been shown recently. Here, we studied four iron oxide nanoparticles, one food pigment E172 and the ionic control FeSO(4) regarding dissolution in biological media, uptake and transport, and cellular effects in vitro in human intestinal Caco-2 and HepaRG hepatocarcinoma cells. The iron oxide nanoparticles passed the gastrointestinal passage without dissolution and reached the intestine in the form of particles. Minor uptake was seen into Caco-2 cells but almost no transport to the basolateral site was detected for any of the tested particles. HepaRG cells showed higher particle uptake. Caco-2 cells showed no alterations in reactive oxygen species production, apoptosis, or mitochondrial membrane potential, whereas two particles induced apoptosis in HepaRG cells, and one altered mitochondrial membrane potential at non-cytotoxic concentrations. No correlation between physicochemical particle characteristics and cellular effects was observed, thus emphasizing the need for case-by-case assessment of iron oxide nanoparticles. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-020-02960-7. |
format | Online Article Text |
id | pubmed-7904561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-79045612021-03-09 Intestinal and hepatic effects of iron oxide nanoparticles Voss, Linn Hoché, Elisa Stock, Valerie Böhmert, Linda Braeuning, Albert Thünemann, Andreas F. Sieg, Holger Arch Toxicol Nanotoxicology Iron oxide nanoparticles gain increasing attention due to their broad industrial use. However, safety concerns exist since their effects on human cells are still under investigation. The presence of iron oxide nanoparticles in the food pigment E172 has been shown recently. Here, we studied four iron oxide nanoparticles, one food pigment E172 and the ionic control FeSO(4) regarding dissolution in biological media, uptake and transport, and cellular effects in vitro in human intestinal Caco-2 and HepaRG hepatocarcinoma cells. The iron oxide nanoparticles passed the gastrointestinal passage without dissolution and reached the intestine in the form of particles. Minor uptake was seen into Caco-2 cells but almost no transport to the basolateral site was detected for any of the tested particles. HepaRG cells showed higher particle uptake. Caco-2 cells showed no alterations in reactive oxygen species production, apoptosis, or mitochondrial membrane potential, whereas two particles induced apoptosis in HepaRG cells, and one altered mitochondrial membrane potential at non-cytotoxic concentrations. No correlation between physicochemical particle characteristics and cellular effects was observed, thus emphasizing the need for case-by-case assessment of iron oxide nanoparticles. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-020-02960-7. Springer Berlin Heidelberg 2021-02-08 2021 /pmc/articles/PMC7904561/ /pubmed/33554279 http://dx.doi.org/10.1007/s00204-020-02960-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Nanotoxicology Voss, Linn Hoché, Elisa Stock, Valerie Böhmert, Linda Braeuning, Albert Thünemann, Andreas F. Sieg, Holger Intestinal and hepatic effects of iron oxide nanoparticles |
title | Intestinal and hepatic effects of iron oxide nanoparticles |
title_full | Intestinal and hepatic effects of iron oxide nanoparticles |
title_fullStr | Intestinal and hepatic effects of iron oxide nanoparticles |
title_full_unstemmed | Intestinal and hepatic effects of iron oxide nanoparticles |
title_short | Intestinal and hepatic effects of iron oxide nanoparticles |
title_sort | intestinal and hepatic effects of iron oxide nanoparticles |
topic | Nanotoxicology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904561/ https://www.ncbi.nlm.nih.gov/pubmed/33554279 http://dx.doi.org/10.1007/s00204-020-02960-7 |
work_keys_str_mv | AT vosslinn intestinalandhepaticeffectsofironoxidenanoparticles AT hocheelisa intestinalandhepaticeffectsofironoxidenanoparticles AT stockvalerie intestinalandhepaticeffectsofironoxidenanoparticles AT bohmertlinda intestinalandhepaticeffectsofironoxidenanoparticles AT braeuningalbert intestinalandhepaticeffectsofironoxidenanoparticles AT thunemannandreasf intestinalandhepaticeffectsofironoxidenanoparticles AT siegholger intestinalandhepaticeffectsofironoxidenanoparticles |